Harvard Health Letter

FDA approves a one-two punch for some strokes

News Briefs Encouraging news on the treatment of strokes caused by blood clots: there are now two first-line therapies to break up the clots and restore blood flow to the brain. In addition to using a clot-busting drug (called tissue plasminogen activator, or tPA), the FDA now says itís okay for doctors to use a device to reach into the blood vessel, grab the clot, and pull it out. Such clot-retrieving devices have…

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In